The results
- Across the three trusts, a total of 2,253 referrals have been made using the TCAM pathway since the introduction of the first pathway in September 2018.
- 64.8% of these referred patients have already received an intervention by their nominated community pharmacist with the remaining patients awaiting contact.
- This is estimated to have accumulated a potential cost avoidance across the system by these providers of £1,783,446 to the local health economies.
- All results data was taken from PharmOutcomes on 16 March 2021.